| Prescribing Matters - Volume 2, Issue 1,
March 2004 |
The
Cure Study - Hype or Hope? |
| Prescribing Matters - Volume 2, Issue 1,
April 2004 |
Risperidone
& Olanzapine contra-indicated for behavioural symptoms
of dementia. |
| Prescribing Matters - Volume 2, Issue 1,
May 2004 |
What
is the place in therapy of angiotensin 2 receptor antagonists? |
| Prescribing Matters - Volume 2, Issue 1,
May 2004 |
Important
drug prescribing issues |
| Prescribing Matters - Volume 2, Issue 3,
May 2004 |
What
is the status of the new BHS guidelines?
Should we be doing this? |
| Prescribing Matters - Volume 2, Issue 4,
June 2004 |
Management
of chronic obstructive pulmonary disease (COPD) based on
NICE Clinical Guideline 12 |
| Prescribing Update - Volume 2, Issue 3,
August 2004 |
This
bulletin is to make prescribers aware of important current
prescribing issues. |
| Prescribing Matters - Volume 2, Issue 5,
October 2004 |
Antibiotic
Prescribing: How can emergence of antibiotic resistance
be delayed? |
| Prescribing Matters - Volume 2, Issue
4, November 2004 |
Is
atenolol a suitable drug for hypertension? |
| Prescribing Matters - Volume 3, Issue
1, February 2005 |
When
should we prescribe drugs in our management of
Osteoporosis? |
| Withdrawal of
co-proxamol |
Download |
| Prescribing Matters - Volume 3, Issue
1, March 2005 |
This
bulletin is to make prescribers aware of important
current prescribing issues |
| Prescribing Matters - Volume 3, Issue
2, March 2005 |
The
new community pharmacy contract |
| Prescribing Matters - Volume 3, Issue
2, July 2005 |
Smoking
cessation therapies |
| Prescribing Update - Issue
2,
August 2005 |
This
bulletin is to increase awareness of important current
prescribing issues |
